Investor's Business Daily40d agoneutral
AstraZeneca Digs $2 Billion Out Of Its Coffers For Summit Deal, Taking On Bristol, Pfizer, MerckNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
MarketBeat55d agoneutral
Merck CEO Sees Pipeline Upside as Launches, Animal Health Drive TransformationThe Wall Street Journal65d agoneutral
The Cancer Vaccine Gold Rush Has Begun. So Has the Race for Picks and Shovels.Investor's Business Daily66d agoneutral
Summit Packs A Punch For Merck's Keytruda - But Not Everyone Is SoldThe Wall Street Journal69d agoneutral
Stock Market Heads for August Gains - Thanks to Unusual WinnersThe Wall Street Journal72d agoneutral
Pharma Industry Stares Down Biggest Patent Cliff in Decades